Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-24

Clinical Trial Update: MESNA Injection for TMJ Internal Derangement [NA]

View source ↗

Summary

The clinical trial evaluating MESNA Injection for temporomandibular joint disorder has completed. Sponsor: Tanta University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MESNA Injection (mesna)

Snippet

Sponsor: Tanta University | Conditions: TMJ Disorder | NA | Status: COMPLETED